Colon cancer strikes men roughly 45% more often than women. Globally, the age-adjusted incidence rate is 23.4 per 100,000 in males compared to 16.2 per 100,000 in females. Of the nearly 1.93 million new colorectal cancer cases recorded worldwide in 2020, men accounted for about 55%. The gap isn’t explained by a single cause. It comes down to a combination of hormonal biology, lifestyle patterns, workplace exposures, and differences in screening behavior.
Estrogen Protects the Colon Lining
The most significant biological factor is estrogen. Premenopausal women have a built-in layer of protection that men simply lack. The colon is lined with a specific type of estrogen receptor that, when activated, triggers several anti-cancer effects at once. It tells damaged cells to self-destruct rather than keep dividing. It dials down inflammation, reducing the activity of key inflammatory signals like TNF-alpha and IL-6 that fuel tumor growth. And it boosts the body’s DNA repair system, increasing production of the proteins responsible for catching and fixing copying errors when cells divide.
Animal studies make the effect strikingly clear. When researchers bred mice without this estrogen receptor, their colon tissue became hyperproliferative: cells divided faster, stopped maturing properly, and lost the tight junctions that hold the gut lining together. Inflammation increased, and early-stage precancerous changes developed more readily. In short, removing estrogen’s influence on the colon created exactly the conditions that lead to cancer.
This helps explain why the gender gap in colorectal cancer narrows after menopause, when women’s estrogen levels drop substantially. It also aligns with findings that hormone replacement therapy in postmenopausal women is associated with lower colorectal cancer risk. Men, who produce far less estrogen throughout their lives, never benefit from this protective mechanism in any meaningful way.
Diet, Alcohol, and Body Composition
Men tend to eat more red and processed meat than women, and the link between processed meat and colorectal cancer is well established. Consuming processed meat regularly is associated with an 18% higher risk of colorectal cancer overall, a 21% higher risk of colon cancer specifically, and a 22% higher risk of rectal cancer. Grilling and barbecuing meat at high temperatures creates additional carcinogenic compounds, further increasing risk.
Alcohol consumption follows a similar pattern. Men drink more on average and are more likely to be heavy drinkers. Alcohol is a known colorectal carcinogen, and the risk climbs with the amount consumed. Combined with higher rates of smoking and greater visceral fat (the deep abdominal fat that surrounds internal organs and promotes chronic inflammation), these lifestyle factors stack the odds against men in a way that compounds over decades.
Occupational Chemical Exposures
Workplace carcinogens add another layer of risk that disproportionately affects men. Workers in leather tanning and fur production face a 70% increased risk of colorectal cancer, driven by exposure to chemicals like formaldehyde, chromium compounds, and various dyes. Iron and steel workers have a 32% elevated risk. Those working in machinery repair and shipyards, where asbestos exposure is common, face a 40% higher risk.
Plastic and rubber manufacturing workers also show increased colorectal cancer rates, likely from exposure to chemicals used in producing resins, polyurethane foam, and polypropylene. Dockyard workers encounter a particularly toxic mix: asbestos, polycyclic aromatic hydrocarbons, aromatic amines, and welding fumes. Because men still make up the majority of workers in heavy industry, mining, and manufacturing, these exposures contribute meaningfully to the overall gender gap in colorectal cancer rates.
Men Are Less Likely to Get Screened
Screening catches precancerous polyps before they become cancer, and men are less likely to stay current with it. In one large study of Medicare beneficiaries, 81.6% of women were up to date on colorectal cancer screening compared to 77.5% of men. After adjusting for other factors like income and education, men were still 28% less likely to be current on screening. That difference matters because colorectal cancer develops slowly from polyps over 10 to 15 years, giving screening a long window to catch and remove growths before they turn malignant.
The screening gap means more men arrive at diagnosis with larger, more advanced tumors. Since early-stage colorectal cancer has a five-year survival rate above 90% while late-stage disease drops dramatically, even modest differences in screening compliance translate into real differences in mortality. Men account for 55% of colorectal cancer deaths worldwide.
Tumors Develop Differently by Sex
Beyond overall rates, the disease itself behaves differently in men and women. Men more frequently develop tumors on the left side of the colon (the descending colon, sigmoid colon, and rectum), with 49.3% of male colon cancers occurring in this location. Women are more likely to develop right-sided tumors, with 59.2% of female colon cancers arising in the ascending colon and cecum.
This distinction matters for both detection and treatment. Left-sided tumors, more common in men, tend to follow the classic cancer progression pathway involving mutations in well-known tumor suppressor genes. These tumors respond well to standard chemotherapy and targeted therapies, and they’re easier to detect through colonoscopy because they often cause noticeable symptoms like bleeding or changes in bowel habits earlier in their course.
Right-sided tumors, more common in women, involve a different molecular pathway tied to DNA repair defects and tend to grow silently for longer before causing symptoms. They’re often larger and more aggressive at diagnosis, less responsive to conventional chemotherapy, though they may respond better to newer immunotherapy approaches. So while men develop colorectal cancer more often, women who do develop it may face a more difficult-to-treat form of the disease.
Why the Gap Matters for Prevention
Understanding these differences has practical implications. For men, the combination of no estrogen protection, higher rates of red meat and alcohol consumption, greater occupational exposures, and lower screening adherence creates a compounding risk profile. Each factor on its own increases risk modestly, but together they produce the consistent 40-50% higher incidence seen across populations worldwide.
The most actionable pieces are the ones you can control: limiting processed meat, reducing alcohol intake, maintaining a healthy weight, and staying current on screening starting at age 45 (or earlier if you have a family history). Given that men face higher baseline risk from biology alone, these lifestyle and screening measures carry even more weight.